Recommendations of Integrated Traditional Chinese and Western Medicine for Diagnosis and Treatment of Novel Coronavirus Pneumonia (COVID-19) in Sichuan Province

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000029558

Enrollment

Unknown

Registered

2020-02-04

Start date

2020-01-29

Completion date

Unknown

Last updated

2020-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

novel coronavirus pneumonia (COVID-19)

Interventions

single arm:Chinese medicine treatment combined with western medicine treatment

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who meet the suspected and confirmed diagnostic criteria for the 2019-nCoV pneumonia version 4.0 of the National Health and Medical Commission (released 2020.01.27).

Exclusion criteria

Exclusion criteria: No exclusion criteria.

Design outcomes

Primary

Measure	Time frame
blood routine;urine routines;CRP;PCT;ESR;creatase;troponin;myoglobin;D-Dimer;arterial blood gas analysis;Nucleic acid test for 2019-nCoV ;chest CT;Biochemical complete set;	—

Countries

China

Contacts

Public ContactXie Chunguang

Hospital of Chengdu University of Traditional Chinese Medicine

xcg718@aliyun.com+86 18980880132

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026